A. Brewster

2.0k total citations
33 papers, 1.2k citations indexed

About

A. Brewster is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, A. Brewster has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 11 papers in Surgery. Recurrent topics in A. Brewster's work include Esophageal Cancer Research and Treatment (11 papers), Gastric Cancer Management and Outcomes (9 papers) and Lung Cancer Diagnosis and Treatment (8 papers). A. Brewster is often cited by papers focused on Esophageal Cancer Research and Treatment (11 papers), Gastric Cancer Management and Outcomes (9 papers) and Lung Cancer Diagnosis and Treatment (8 papers). A. Brewster collaborates with scholars based in United Kingdom, United States and Canada. A. Brewster's co-authors include Tim Maughan, Tom Crosby, Ruth E. Langley, Wyn G. Lewis, Michel Seymour, Harpreet Wasan, Lindsay C Thompson, S.A. Roberts, Mahesh Parmar and Gary Middleton and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

A. Brewster

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Brewster United Kingdom 16 587 499 414 117 107 33 1.2k
C.J.H. van de Velde Netherlands 21 788 1.3× 389 0.8× 604 1.5× 178 1.5× 117 1.1× 39 1.5k
Maria Rosaria Valerio Italy 21 745 1.3× 310 0.6× 308 0.7× 156 1.3× 154 1.4× 94 1.4k
Baktiar Hasan Belgium 21 658 1.1× 1.4k 2.7× 337 0.8× 145 1.2× 79 0.7× 45 1.8k
Vanita Noronha India 16 456 0.8× 404 0.8× 181 0.4× 174 1.5× 21 0.2× 97 1.0k
R. Adam France 13 947 1.6× 454 0.9× 625 1.5× 214 1.8× 33 0.3× 27 1.7k
Laurence Gladieff France 24 752 1.3× 242 0.5× 531 1.3× 213 1.8× 140 1.3× 135 1.9k
Heath B. Mackley United States 21 538 0.9× 298 0.6× 199 0.5× 60 0.5× 94 0.9× 59 1.1k
Michele De Tursi Italy 18 576 1.0× 310 0.6× 144 0.3× 105 0.9× 117 1.1× 60 1.3k
Andreas Marinelli Netherlands 21 1.1k 1.8× 279 0.6× 914 2.2× 82 0.7× 47 0.4× 47 1.5k
Jyoti Bajpai India 18 441 0.8× 382 0.8× 198 0.5× 134 1.1× 28 0.3× 123 1.1k

Countries citing papers authored by A. Brewster

Since Specialization
Citations

This map shows the geographic impact of A. Brewster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Brewster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Brewster more than expected).

Fields of papers citing papers by A. Brewster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Brewster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Brewster. The network helps show where A. Brewster may publish in the future.

Co-authorship network of co-authors of A. Brewster

This figure shows the co-authorship network connecting the top 25 collaborators of A. Brewster. A scholar is included among the top collaborators of A. Brewster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Brewster. A. Brewster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Middleton, Gary, Sanjay Popat, Yvonne Summers, et al.. (2019). PL02.09 National Lung Matrix Trial (NLMT): First Results from an Umbrella Phase II Trial in Advanced Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 14(10). S7–S7. 1 indexed citations
3.
Saunders, Mark, James Paul, Gordon Brown, et al.. (2018). SCOT: Tumor sidedness and the influence of chemotherapy duration on DFS.. Journal of Clinical Oncology. 36(4_suppl). 558–558.
4.
Scurr, Martin, Tom Pembroke, Anja Bloom, et al.. (2017). Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer. Clinical Cancer Research. 23(22). 6771–6780. 119 indexed citations
5.
6.
Seymour, Michel, Lindsay C Thompson, Harpreet Wasan, et al.. (2011). Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial. The Lancet. 377(9779). 1749–1759. 270 indexed citations
7.
Hudson, Emma, Chris Hurt, D. Mort, et al.. (2009). Induction Chemotherapy Followed by Chemoradiation in Locally Advanced Pancreatic Cancer: an Effective and Well-tolerated Treatment. Clinical Oncology. 22(1). 27–35. 13 indexed citations
8.
Morgan, Matthew A., Wyn G. Lewis, Andrew N. Hopper, et al.. (2007). Prospective comparison of transthoracic versus transhiatal esophagectomy following neoadjuvant therapy for esophageal cancer. Diseases of the Esophagus. 20(3). 225–231. 22 indexed citations
9.
Powell, J., Saptarshi Mukherjee, T. Crosby, et al.. (2007). Small cell oesophageal carcinoma: an institutional experience and review of the literature. British Journal of Cancer. 96(5). 708–711. 50 indexed citations
10.
Morgan, Matthew A., Wyn G. Lewis, Andrew N. Hopper, et al.. (2006). Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer. Diseases of the Esophagus. 20(1). 29–35. 42 indexed citations
11.
Mukherjee, Somnath, A. Brewster, Richard Hardwick, et al.. (2006). Pilot Study of Preoperative Combined Modality Treatment for Locally Advanced Operable Oesophageal Carcinoma: Toxicities and Long-term Outcome. Clinical Oncology. 18(4). 338–344. 6 indexed citations
12.
Stephens, Michael, Wyn G. Lewis, A. Brewster, et al.. (2006). Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. Diseases of the Esophagus. 19(3). 164–171. 211 indexed citations
13.
Adams, Richard, Matthew A. Morgan, Somnath Mukherjee, et al.. (2006). A prospective comparison of multidisciplinary treatment of oesophageal cancer with curative intent in a UK cancer network. European Journal of Surgical Oncology. 33(3). 307–313. 29 indexed citations
14.
Lester, J.F., Emma Hudson, M. Flubacher, et al.. (2006). Small Cell Lung Cancer Treated in Southeast Wales. Clinical Oncology. 18(5). 378–382. 4 indexed citations
15.
Crosby, T., et al.. (2004). Definitive chemoradiation in patients with inoperable oesophageal carcinoma. British Journal of Cancer. 90(1). 70–75. 90 indexed citations
16.
Lester, J.F., et al.. (2004). CT-planned accelerated hypofractionated radiotherapy in the radical treatment of non-small cell lung cancer. Lung Cancer. 45(2). 237–242. 21 indexed citations
17.
Toy, Edmond L., et al.. (2001). Chemoradiotherapy for carcinoma of the oesophagus: Experience of a single institution. British Journal of Cancer. 85. 104–104. 2 indexed citations
18.
Brewster, A., S.E. Davidson, Wendy Makin, R. Stout, & P.A. Burt. (1995). Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus. Clinical Oncology. 7(2). 102–105. 34 indexed citations
19.
Brewster, A., P. Hopwood, R. Stout, P.A. Burt, & Nicholas Thatcher. (1995). Single fraction prophylactic cranial irradiation for small cell carcinoma of the lung. Radiotherapy and Oncology. 34(2). 132–136. 11 indexed citations
20.
Brewster, A., et al.. (1994). Microfabricated printed circuit for measuring oxygenin vitro. Medical & Biological Engineering & Computing. 32(5). 576–579. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C.J.H. van de Velde Breakdown of academic impact, for papers by Maria Rosaria Valerio Breakdown of academic impact, for papers by Baktiar Hasan Breakdown of academic impact, for papers by Vanita Noronha Breakdown of academic impact, for papers by R. Adam Breakdown of academic impact, for papers by Laurence Gladieff Breakdown of academic impact, for papers by Heath B. Mackley Breakdown of academic impact, for papers by Michele De Tursi Breakdown of academic impact, for papers by Andreas Marinelli Breakdown of academic impact, for papers by Jyoti Bajpai
Rankless by CCL
2026